These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26052251)

  • 21. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Zhao Z; Liang S; Sun F
    Front Oncol; 2020; 10():1172. PubMed ID: 32850336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death.
    Gupta S; Silveira DA; Mombach JCM; Hashimoto RF
    Noncoding RNA Res; 2023 Dec; 8(4):605-614. PubMed ID: 37767112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway.
    Liu Y; Liu X; Zhang X; Deng J; Zhang J; Xing H
    Cancer Manag Res; 2020; 12():2685-2695. PubMed ID: 32368147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.
    Xie J; Wu Y; Bian X; Chen D; Gui Q; Huang J
    Int J Clin Exp Pathol; 2018; 11(7):3703-3707. PubMed ID: 31949753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
    Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
    Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
    Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375.
    Xu N; Qiao L; Yin L; Li H
    J BUON; 2019; 24(6):2273-2279. PubMed ID: 31983094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC.
    Gong W; Cao Y; Wang Y; Yang L; Su W; Qiu F; Datta S; Rao B; Xian J; Lin M; Feng Y; Zhang X; Zhou Y; Gao X; Lu J
    Pathol Res Pract; 2018 Jun; 214(6):857-861. PubMed ID: 29709443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between lncRNAs in plasma exosomes and diabetic retinopathy.
    Ye Q; Li L; Shao Z; Xu M; Li L; Yan Q; Huang B; Zhao T
    Front Endocrinol (Lausanne); 2022; 13():987488. PubMed ID: 36187126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.
    Zhang RM; Tang T; Yu HM; Yao XD
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):260-266. PubMed ID: 30442366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
    Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies of LncRNA DLX6-AS1 on Study and Therapeutics.
    Zhao Y; Li P
    Front Genet; 2022; 13():871988. PubMed ID: 35719380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.